Effect of paliperidone palmitate 3-month formulation on goal attainment and disability after 52 weeks’ treatment in patients with clinically stable schizophrenia

  1. Lambert, M.
  2. Sanchez, P.
  3. Bergmans, P.
  4. Gopal, S.
  5. Mathews, M.
  6. Wooller, A.
  7. Pungor, K.
Aldizkaria:
Neuropsychiatric Disease and Treatment

ISSN: 1178-2021

Argitalpen urtea: 2020

Alea: 16

Orrialdeak: 3197-3208

Mota: Artikulua

DOI: 10.2147/NDT.S286654 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus